[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Recombinant Therapeutic Protein Market Professional Survey Report 2017

October 2017 | 102 pages | ID: G6CA91F77CCEN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies Recombinant Therapeutic Protein in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celldex Therapeutics
  • Eli Liily
  • GlaxoSmithKline
  • Merck
  • Novartis
  • Regeneron Pharmaceuticals
  • Roche
  • Shire Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Recombinant Human Collage
  • Recombinant Human Serum Albumin
By Application, the market can be split into
  • Medicine
  • Scientific Research
  • Others
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • China
  • Europe
  • Southeast Asia
  • Japan
  • India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Recombinant Therapeutic Protein Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF RECOMBINANT THERAPEUTIC PROTEIN

1.1 Definition and Specifications of Recombinant Therapeutic Protein
  1.1.1 Definition of Recombinant Therapeutic Protein
  1.1.2 Specifications of Recombinant Therapeutic Protein
1.2 Classification of Recombinant Therapeutic Protein
  1.2.1 Recombinant Human Collage
  1.2.2 Recombinant Human Serum Albumin
1.3 Applications of Recombinant Therapeutic Protein
  1.3.1 Medicine
  1.3.2 Scientific Research
  1.3.3 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF RECOMBINANT THERAPEUTIC PROTEIN

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Recombinant Therapeutic Protein
2.3 Manufacturing Process Analysis of Recombinant Therapeutic Protein
2.4 Industry Chain Structure of Recombinant Therapeutic Protein

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF RECOMBINANT THERAPEUTIC PROTEIN

3.1 Capacity and Commercial Production Date of Global Recombinant Therapeutic Protein Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Recombinant Therapeutic Protein Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Recombinant Therapeutic Protein Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Recombinant Therapeutic Protein Major Manufacturers in 2016

4 GLOBAL RECOMBINANT THERAPEUTIC PROTEIN OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Recombinant Therapeutic Protein Capacity and Growth Rate Analysis
  4.2.2 2016 Recombinant Therapeutic Protein Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Recombinant Therapeutic Protein Sales and Growth Rate Analysis
  4.3.2 2016 Recombinant Therapeutic Protein Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Recombinant Therapeutic Protein Sales Price
  4.4.2 2016 Recombinant Therapeutic Protein Sales Price Analysis (Company Segment)

5 RECOMBINANT THERAPEUTIC PROTEIN REGIONAL MARKET ANALYSIS

5.1 North America Recombinant Therapeutic Protein Market Analysis
  5.1.1 North America Recombinant Therapeutic Protein Market Overview
  5.1.2 North America 2012-2017E Recombinant Therapeutic Protein Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Recombinant Therapeutic Protein Sales Price Analysis
  5.1.4 North America 2016 Recombinant Therapeutic Protein Market Share Analysis
5.2 China Recombinant Therapeutic Protein Market Analysis
  5.2.1 China Recombinant Therapeutic Protein Market Overview
  5.2.2 China 2012-2017E Recombinant Therapeutic Protein Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Recombinant Therapeutic Protein Sales Price Analysis
  5.2.4 China 2016 Recombinant Therapeutic Protein Market Share Analysis
5.3 Europe Recombinant Therapeutic Protein Market Analysis
  5.3.1 Europe Recombinant Therapeutic Protein Market Overview
  5.3.2 Europe 2012-2017E Recombinant Therapeutic Protein Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Recombinant Therapeutic Protein Sales Price Analysis
  5.3.4 Europe 2016 Recombinant Therapeutic Protein Market Share Analysis
5.4 Southeast Asia Recombinant Therapeutic Protein Market Analysis
  5.4.1 Southeast Asia Recombinant Therapeutic Protein Market Overview
  5.4.2 Southeast Asia 2012-2017E Recombinant Therapeutic Protein Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Recombinant Therapeutic Protein Sales Price Analysis
  5.4.4 Southeast Asia 2016 Recombinant Therapeutic Protein Market Share Analysis
5.5 Japan Recombinant Therapeutic Protein Market Analysis
  5.5.1 Japan Recombinant Therapeutic Protein Market Overview
  5.5.2 Japan 2012-2017E Recombinant Therapeutic Protein Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Recombinant Therapeutic Protein Sales Price Analysis
  5.5.4 Japan 2016 Recombinant Therapeutic Protein Market Share Analysis
5.6 India Recombinant Therapeutic Protein Market Analysis
  5.6.1 India Recombinant Therapeutic Protein Market Overview
  5.6.2 India 2012-2017E Recombinant Therapeutic Protein Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Recombinant Therapeutic Protein Sales Price Analysis
  5.6.4 India 2016 Recombinant Therapeutic Protein Market Share Analysis

6 GLOBAL 2012-2017E RECOMBINANT THERAPEUTIC PROTEIN SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Recombinant Therapeutic Protein Sales by Type
6.2 Different Types of Recombinant Therapeutic Protein Product Interview Price Analysis
6.3 Different Types of Recombinant Therapeutic Protein Product Driving Factors Analysis
  6.3.1 Recombinant Human Collage of Recombinant Therapeutic Protein Growth Driving Factor Analysis
  6.3.2 Recombinant Human Serum Albumin of Recombinant Therapeutic Protein Growth Driving Factor Analysis

7 GLOBAL 2012-2017E RECOMBINANT THERAPEUTIC PROTEIN SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Recombinant Therapeutic Protein Consumption by Application
7.2 Different Application of Recombinant Therapeutic Protein Product Interview Price Analysis
7.3 Different Application of Recombinant Therapeutic Protein Product Driving Factors Analysis
  7.3.1 Medicine of Recombinant Therapeutic Protein Growth Driving Factor Analysis
  7.3.2 Scientific Research of Recombinant Therapeutic Protein Growth Driving Factor Analysis
  7.3.3 Others of Recombinant Therapeutic Protein Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF RECOMBINANT THERAPEUTIC PROTEIN

8.1 Boehringer Ingelheim
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Boehringer Ingelheim 2016 Recombinant Therapeutic Protein Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Boehringer Ingelheim 2016 Recombinant Therapeutic Protein Business Region Distribution Analysis
8.2 Bristol-Myers Squibb
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Bristol-Myers Squibb 2016 Recombinant Therapeutic Protein Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Bristol-Myers Squibb 2016 Recombinant Therapeutic Protein Business Region Distribution Analysis
8.3 Celldex Therapeutics
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Celldex Therapeutics 2016 Recombinant Therapeutic Protein Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Celldex Therapeutics 2016 Recombinant Therapeutic Protein Business Region Distribution Analysis
8.4 Eli Liily
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Eli Liily 2016 Recombinant Therapeutic Protein Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Eli Liily 2016 Recombinant Therapeutic Protein Business Region Distribution Analysis
8.5 GlaxoSmithKline
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 GlaxoSmithKline 2016 Recombinant Therapeutic Protein Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 GlaxoSmithKline 2016 Recombinant Therapeutic Protein Business Region Distribution Analysis
8.6 Merck
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Merck 2016 Recombinant Therapeutic Protein Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Merck 2016 Recombinant Therapeutic Protein Business Region Distribution Analysis
8.7 Novartis
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Novartis 2016 Recombinant Therapeutic Protein Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Novartis 2016 Recombinant Therapeutic Protein Business Region Distribution Analysis
8.8 Regeneron Pharmaceuticals
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Regeneron Pharmaceuticals 2016 Recombinant Therapeutic Protein Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Regeneron Pharmaceuticals 2016 Recombinant Therapeutic Protein Business Region Distribution Analysis
8.9 Roche
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Roche 2016 Recombinant Therapeutic Protein Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Roche 2016 Recombinant Therapeutic Protein Business Region Distribution Analysis
8.10 Shire Pharmaceuticals
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Shire Pharmaceuticals 2016 Recombinant Therapeutic Protein Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Shire Pharmaceuticals 2016 Recombinant Therapeutic Protein Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF RECOMBINANT THERAPEUTIC PROTEIN MARKET

9.1 Global Recombinant Therapeutic Protein Market Trend Analysis
  9.1.1 Global 2017-2022 Recombinant Therapeutic Protein Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Recombinant Therapeutic Protein Sales Price Forecast
9.2 Recombinant Therapeutic Protein Regional Market Trend
  9.2.1 North America 2017-2022 Recombinant Therapeutic Protein Consumption Forecast
  9.2.2 China 2017-2022 Recombinant Therapeutic Protein Consumption Forecast
  9.2.3 Europe 2017-2022 Recombinant Therapeutic Protein Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Recombinant Therapeutic Protein Consumption Forecast
  9.2.5 Japan 2017-2022 Recombinant Therapeutic Protein Consumption Forecast
  9.2.6 India 2017-2022 Recombinant Therapeutic Protein Consumption Forecast
9.3 Recombinant Therapeutic Protein Market Trend (Product Type)
9.4 Recombinant Therapeutic Protein Market Trend (Application)

10 RECOMBINANT THERAPEUTIC PROTEIN MARKETING TYPE ANALYSIS

10.1 Recombinant Therapeutic Protein Regional Marketing Type Analysis
10.2 Recombinant Therapeutic Protein International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Recombinant Therapeutic Protein by Region
10.4 Recombinant Therapeutic Protein Supply Chain Analysis

11 CONSUMERS ANALYSIS OF RECOMBINANT THERAPEUTIC PROTEIN

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL RECOMBINANT THERAPEUTIC PROTEIN MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Therapeutic Protein
Table Product Specifications of Recombinant Therapeutic Protein
Table Classification of Recombinant Therapeutic Protein
Figure Global Production Market Share of Recombinant Therapeutic Protein by Type in 2016
Figure Recombinant Human Collage Picture
Table Major Manufacturers of Recombinant Human Collage
Figure Recombinant Human Serum Albumin Picture
Table Major Manufacturers of Recombinant Human Serum Albumin
Table Applications of Recombinant Therapeutic Protein
Figure Global Consumption Volume Market Share of Recombinant Therapeutic Protein by Application in 2016
Figure Medicine Examples
Table Major Consumers in Medicine
Figure Scientific Research Examples
Table Major Consumers in Scientific Research
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Recombinant Therapeutic Protein by Regions
Figure North America Recombinant Therapeutic Protein Market Size (Million USD) (2012-2022)
Figure China Recombinant Therapeutic Protein Market Size (Million USD) (2012-2022)
Figure Europe Recombinant Therapeutic Protein Market Size (Million USD) (2012-2022)
Figure Southeast Asia Recombinant Therapeutic Protein Market Size (Million USD) (2012-2022)
Figure Japan Recombinant Therapeutic Protein Market Size (Million USD) (2012-2022)
Figure India Recombinant Therapeutic Protein Market Size (Million USD) (2012-2022)
Table Recombinant Therapeutic Protein Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Recombinant Therapeutic Protein in 2016
Figure Manufacturing Process Analysis of Recombinant Therapeutic Protein
Figure Industry Chain Structure of Recombinant Therapeutic Protein
Table Capacity and Commercial Production Date of Global Recombinant Therapeutic Protein Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Recombinant Therapeutic Protein Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Recombinant Therapeutic Protein Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Recombinant Therapeutic Protein Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Recombinant Therapeutic Protein 2012-2017
Figure Global 2012-2017E Recombinant Therapeutic Protein Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Recombinant Therapeutic Protein Market Size (Value) and Growth Rate
Table 2012-2017E Global Recombinant Therapeutic Protein Capacity and Growth Rate
Table 2016 Global Recombinant Therapeutic Protein Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Recombinant Therapeutic Protein Sales (K Pcs) and Growth Rate
Table 2016 Global Recombinant Therapeutic Protein Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Recombinant Therapeutic Protein Sales Price (USD/Pcs)
Table 2016 Global Recombinant Therapeutic Protein Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Recombinant Therapeutic Protein 2012-2017E
Figure North America 2012-2017E Recombinant Therapeutic Protein Sales Price (USD/Pcs)
Figure North America 2016 Recombinant Therapeutic Protein Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Recombinant Therapeutic Protein 2012-2017E
Figure China 2012-2017E Recombinant Therapeutic Protein Sales Price (USD/Pcs)
Figure China 2016 Recombinant Therapeutic Protein Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Recombinant Therapeutic Protein 2012-2017E
Figure Europe 2012-2017E Recombinant Therapeutic Protein Sales Price (USD/Pcs)
Figure Europe 2016 Recombinant Therapeutic Protein Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Recombinant Therapeutic Protein 2012-2017E
Figure Southeast Asia 2012-2017E Recombinant Therapeutic Protein Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Recombinant Therapeutic Protein Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Recombinant Therapeutic Protein 2012-2017E
Figure Japan 2012-2017E Recombinant Therapeutic Protein Sales Price (USD/Pcs)
Figure Japan 2016 Recombinant Therapeutic Protein Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Recombinant Therapeutic Protein 2012-2017E
Figure India 2012-2017E Recombinant Therapeutic Protein Sales Price (USD/Pcs)
Figure India 2016 Recombinant Therapeutic Protein Sales Market Share
Table Global 2012-2017E Recombinant Therapeutic Protein Sales (K Pcs) by Type
Table Different Types Recombinant Therapeutic Protein Product Interview Price
Table Global 2012-2017E Recombinant Therapeutic Protein Sales (K Pcs) by Application
Table Different Application Recombinant Therapeutic Protein Product Interview Price
Table Boehringer Ingelheim Information List
Table Product A Overview
Table Product B Overview
Table 2016 Boehringer Ingelheim Recombinant Therapeutic Protein Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Boehringer Ingelheim Recombinant Therapeutic Protein Business Region Distribution
Table Bristol-Myers Squibb Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bristol-Myers Squibb Recombinant Therapeutic Protein Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Bristol-Myers Squibb Recombinant Therapeutic Protein Business Region Distribution
Table Celldex Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2015 Celldex Therapeutics Recombinant Therapeutic Protein Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Celldex Therapeutics Recombinant Therapeutic Protein Business Region Distribution
Table Eli Liily Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Liily Recombinant Therapeutic Protein Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Eli Liily Recombinant Therapeutic Protein Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Recombinant Therapeutic Protein Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 GlaxoSmithKline Recombinant Therapeutic Protein Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Recombinant Therapeutic Protein Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Merck Recombinant Therapeutic Protein Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Recombinant Therapeutic Protein Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Novartis Recombinant Therapeutic Protein Business Region Distribution
Table Regeneron Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Recombinant Therapeutic Protein Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Roche Recombinant Therapeutic Protein Business Region Distribution
Table Shire Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Shire Pharmaceuticals Recombinant Therapeutic Protein Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Shire Pharmaceuticals Recombinant Therapeutic Protein Business Region Distribution
Figure Global 2017-2022 Recombinant Therapeutic Protein Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Recombinant Therapeutic Protein Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Recombinant Therapeutic Protein Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Recombinant Therapeutic Protein Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Recombinant Therapeutic Protein Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Recombinant Therapeutic Protein Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Recombinant Therapeutic Protein Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Recombinant Therapeutic Protein Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Recombinant Therapeutic Protein Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Recombinant Therapeutic Protein by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Recombinant Therapeutic Protein by Application 2017-2022
Table Traders or Distributors with Contact Information of Recombinant Therapeutic Protein by Region


More Publications